Please ensure Javascript is enabled for purposes of website accessibility
Gilead's $2,340 Price for Coronavirus Drug Draws Criticism
gvw_ap_news
By Associated Press
Published 5 years ago on
June 29, 2020

Share

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.
“We believe that we had to really deviate from the normal circumstances” and price the drug to ensure wide access rather than based solely on value to patients, he said.
However, the price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug’s development.
The treatment courses that the company has donated to the U.S. and other countries will run out in about a week, and the prices will apply to the drug after that, O’Day said.
In the U.S., federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September. They said Monday that the government has secured more than 500,000 additional courses that Gilead will produce starting in July to supply to hospitals through September, and stressed that that does not mean the government actually was acquiring that much, just ensuring the availability.

Drug Interferes With Coronavirus’ Ability to Copy Its Genetic Material

“We should have sufficient supply … but we have to make sure it’s in the right place at the right time,” O’Day said
In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course.
Remdesivir’s price has been highly anticipated since it became the first medicine to show benefit in the pandemic, which has killed more than half a million people globally in six months.
The drug interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. It had not improved survival according to preliminary results after two weeks of followup; results after four weeks are expected soon.
The Institute for Clinical and Economic Review, a nonprofit group that analyzes drug prices, said remdesivir would be cost-effective in a range of $4,580 to $5,080 if it saved lives. But recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between $2,520 and $2,800, the group said.
“This is a high price for a drug that has not been shown to reduce mortality,” Dr. Steven Nissen of the Cleveland Clinic said in an email. “Given the serious nature of the pandemic, I would prefer that the government take over production and distribute the drug for free. It was developed using significant taxpayer funding.”

Drug Has Emergency Use Authorization in the US

Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.”

While it may be a sticker shock for many, “from the health system perspective, if remdesivir can shorten duration of hospitalization by four days, then the medicine provides a reasonable value,” Dr. David Boulware, an infectious disease specialist at the University of Minnesota, said in an email.
“Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said.
“The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert at Memorial Sloan Kettering Cancer Center in New York said in an email. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”
While it may be a sticker shock for many, “from the health system perspective, if remdesivir can shorten duration of hospitalization by four days, then the medicine provides a reasonable value,” Dr. David Boulware, an infectious disease specialist at the University of Minnesota, said in an email.
O’Day said that shortening hospitalization saves about $12,000 per patient. Gilead says it will have spent $1 billion on developing and making the drug by the end of this year.
The drug has emergency use authorization in the U.S. and Gilead has applied for full approval.

RELATED TOPICS:

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Tulare County Man Arrested After Firing at Deputies During Eviction Attempt

DON'T MISS

If ex-Bitwise CEOs Behave in Prison, How Much Less Time Will They Serve?

DON'T MISS

Trump Just Bet the Farm

DON'T MISS

Staged Crashes and Insurance Fraud: Is Your California Commute a Target?

DON'T MISS

Fight Over Phonics: Will CA Require the ‘Science of Reading’ in K-12 Schools?

DON'T MISS

Russia Says Trump’s Threats Against Iran Could Trigger ‘Global Catastrophe’

DON'T MISS

Get Off the Phone! Fresno Police Target Distracted Driving

DON'T MISS

Federal Reserve Chief Says Trump Tariffs Likely to Raise Inflation and Slow US Economic Growth

DON'T MISS

The NBA’s Playoff Chase Enters Its Final Days. Here’s a Look at What’s Happening

DON'T MISS

USC’s JuJu Watkins Named AP Player of the Year After Historic Sophomore Season

UP NEXT

USC’s JuJu Watkins Named AP Player of the Year After Historic Sophomore Season

UP NEXT

Dodgers’ Freddie Freeman Lands on Injured List Following Fall in His Shower at Home

UP NEXT

Curry Scores 37 Points and Warriors Beat Lakers in a Potential First-Round Playoff Preview

UP NEXT

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

UP NEXT

Startup Offers Controversial Microplastic Blood Cleansing Treatment

UP NEXT

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

UP NEXT

Flores Homers, Matos and Wade Also Go Deep to Help Giants Cap Sweep of Astros

UP NEXT

Trump Proposes Tax Deduction for Auto Loan Interest on US-Made Cars

UP NEXT

Western US Sees Sharp Increase in Extreme Weather Impact

UP NEXT

7-Year-Old Girl Was Killed by a Falling Boulder at a Lake Tahoe Ski Resort

Staged Crashes and Insurance Fraud: Is Your California Commute a Target?

54 minutes ago

Fight Over Phonics: Will CA Require the ‘Science of Reading’ in K-12 Schools?

59 minutes ago

Russia Says Trump’s Threats Against Iran Could Trigger ‘Global Catastrophe’

2 hours ago

Get Off the Phone! Fresno Police Target Distracted Driving

2 hours ago

Federal Reserve Chief Says Trump Tariffs Likely to Raise Inflation and Slow US Economic Growth

2 hours ago

The NBA’s Playoff Chase Enters Its Final Days. Here’s a Look at What’s Happening

2 hours ago

USC’s JuJu Watkins Named AP Player of the Year After Historic Sophomore Season

2 hours ago

Dodgers’ Freddie Freeman Lands on Injured List Following Fall in His Shower at Home

2 hours ago

How Trump’s Latest Tariffs Could Affect Your Wallet

2 hours ago

Curry Scores 37 Points and Warriors Beat Lakers in a Potential First-Round Playoff Preview

2 hours ago

Tulare County Man Arrested After Firing at Deputies During Eviction Attempt

A Porterville man accused of opening fire on Tulare County Sheriff’s deputies during an attempted eviction was arrested late Thursday, autho...

14 minutes ago

Kenneth Bratton, 43, was arrested after allegedly firing at Tulare County Sheriff’s deputies during an eviction attempt in Porterville. (Tulare County SO)
14 minutes ago

Tulare County Man Arrested After Firing at Deputies During Eviction Attempt

24 minutes ago

If ex-Bitwise CEOs Behave in Prison, How Much Less Time Will They Serve?

48 minutes ago

Trump Just Bet the Farm

54 minutes ago

Staged Crashes and Insurance Fraud: Is Your California Commute a Target?

59 minutes ago

Fight Over Phonics: Will CA Require the ‘Science of Reading’ in K-12 Schools?

2 hours ago

Russia Says Trump’s Threats Against Iran Could Trigger ‘Global Catastrophe’

The Fresno Police Department will conduct an enforcement operation on April 7, 2025, to target drivers violating the hands-free cell phone law, aiming to reduce distracted driving. (Shutterstock)
2 hours ago

Get Off the Phone! Fresno Police Target Distracted Driving

Federal Reserve Chair Jerome Powell speaks during a news conference after the Federal Open Market Committee meeting, Wednesday, March 19, 2025, at the Federal Reserve in Washington. (AP Photo/Jacquelyn Martin)
2 hours ago

Federal Reserve Chief Says Trump Tariffs Likely to Raise Inflation and Slow US Economic Growth

Help continue the work that gets you the news that matters most.

Search

Send this to a friend